You know I have to copy and paste...I am tired.  To

New Post Public Reply Private Reply Replies (1) Message Board
patientgal
You know I have to copy and paste...I am tired. 

To paraphrase something Dr. Koos said today: 

The fall is going to bring out better investors as this summer winds down.

The IND application for the MIN science is close at hand. Do not ask the exact time for we are not so daft that we would dare try to squeeze this out of the company. But it is very close. 

Hema...waiting on the FDA (please see my number of posts regarding the FDA and the time it takes. I do have a little bit of experience in the world of pharma. Just a weeeeeeeeee bit) Everything the FDA requested has been provided. No ifs, ands or buts about it. 

If you consider the second line of this post and couple it with the fact that BMSN have been true to their timeline AND the significant amount of dd already provided, you should be able to deduce the unfolding of all of the monumental events that are occurring. But do not expect these things to happen over night--this is not child's play--this successfully introducing a revolutionary way of thinking about how to efficiently treat diseases that have plagued us for as long as we can remember. 

Too, this is being done by a company that is minimizing the number of people or entities that they are beholden to so that shareholder interest is secured. For anyone that has ever operated their own business, you know this is no easy task. 

As I and several others have pointed out, this company is still going strong in the face of incredible adversity; they have kept to their timeline, they have faced the FDA head on (no easy task I tell you), they have secured an agreement with a company that has strong ties to BP, they brought us up-to-date with the current financial status of pending affairs and have done so with a constant barrage of baseless & inflammatory accusations and a PPS that is manipulated as though it belongs to a company promising to harvest King Crabs from the freshwater pond in my back yard. To do this requires fortitude, commitment, ingenuity and a whole lotta teamwork. 

I want you all to remember that we are not the only ones eyeing BMSN. If you care to dig enough and piss enough people off with your refusal to shut up, you, TOO, can confirm this. When these folks jump in, Lawd is my life going to be so much easier! 

I am delighted that I will have the opportunity to meet with Dr. Koos & Dr. Ichim with Inventor near the end of the month. At which time I will revert with as much information as the law allows. 

AND I will change my profile pic to show me cuddling Koos! (Tee, hee). :-p 

PS: I have iggied a lot of people the past two days based on the sound advise received from a very wise and knowledgeable fellow investor that caused a light bulb to go off for me on Saturday morning I believe it was. I do know they are talking...I just have no idea what they are saying. 

Almost forgot, if you leave a detailed message and not spew diatribes at Dr. Koos, he will return your call. Might take a wee while as he gets MANY from iHub members. But, if you are respectful and provide a legitimate query, he will call you back. Don't expect him to entertain the BS, though. 

I am tired. Very tired. So, goodnight most. And to most a good night. 

LONG & STRONGER THAN EVER, BMSN!

RIVULET MEDIA INC. (RIVU) Stock Research Links

RIVU Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 19

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 10

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 22

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 16

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 9

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 13

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 21

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Niterra and Rackspace: Seamless Migration to Google Cloud

Updated Category News Views 126

Niterra and Rackspace: A Strategic Partnership for Cloud Migration Niterra EMEA GmbH has taken a monumental step in its digital transformation journey by partnering with Rackspace Technology. This collaboration aims to enhance operational efficiency through a swift migration to Google Cloud, capitalizing on Rackspace's extensive expertise in handling business-critical...

Continue Reading
Sweden Procures Four C-390 Millennium Aircraft from Embraer

Updated Category News Views 123

Sweden's Announcement on C-390 Millennium Acquisition In a significant development for military aviation, Sweden has officially committed to acquiring four C-390 Millennium multi-mission aircraft from Embraer. This strategic move is expected to enhance Sweden's defense capabilities and interoperability within NATO. Details of the Agreement The acquisition announcement...

Continue Reading
MindMed Initiates Phase 3 Study for MM120 in Anxiety Treatment

Updated Category News Views 332

MindMed Begins Journey with Phase 3 Study of MM120 Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) has crossed a significant milestone in its mission to provide breakthrough treatments for brain health disorders. The clinical-stage biopharmaceutical company has announced that the first patient is now dosed in its pivotal Phase 3 Voyage study of MM120 Orally Disintegrating...

Continue Reading
Global Office Furniture Market Set to Expand Significantly

Updated Category News Views 62

Growth Overview of the Office Furniture Market The global office furniture market is currently experiencing steady growth, fueled by the rising popularity of flexible and hybrid work environments. This shift is creating a strong demand for adaptable and ergonomic furniture that works well in both home and office contexts. As businesses evolve and expand, there’s an...

Continue Reading
Understanding Fiscal Dominance and Its Impact on Bond Markets

Updated Category News Views 467

Understanding Fiscal Dominance and Its Effects Fiscal dominance is an increasingly important concept in today's economic discussions, especially for those keen on understanding market dynamics. This economic principle involves a scenario where ongoing primary fiscal deficits stimulate nominal growth while the Central Bank maintains a loose monetary policy, failing to...

Continue Reading